Wavemaker 360
VC Fund
Pasadena, United States
Wavemaker 360 is a VC fund in Pasadena focused on Health Care and Medical. Wavemaker Three-Sixty Health is the leading U.S. early-stage (Seed and following on at the Series A) venture capital fund focused 100% on healthcare. Launched in 2018, Wavemaker 360 invested into the most promising healthcare startups in North America, with LPs from every sector of the US healthcare system. We are SEEDING HEALTHCARE'STOMORROW. We invest in healthcare disruptors and entrepreneurs that see how the industry is transforming itself and want to make a big difference.
- Total investments:
- 89
- Last investment:
- Lead investor:
- 11%
- Fund size:
- $64M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Wavemaker 360 invests in
Stages Wavemaker 360 invests in
Countries Wavemaker 360 invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $750k–$6M
- Series A
- $1.9M–$20M
- Series B
- $5M–$30M
Investment Focus
Industry
- Health Care 46 (52%)
- Medical 22 (25%)
- Artificial Intelligence 12 (13%)
- Medical Device 10 (11%)
- Biotechnology 9 (10%)
Stage
- Seed 50 (56%)
- Series A 21 (24%)
- Series B 3 (3%)
- Venture - Series Unknown 2 (2%)
- Pre-Seed 1 (1%)
Country
- United States 54 (61%)
- United Kingdom 5 (6%)
- Canada 2 (2%)
- Singapore 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Lisa Riedmiller
Chief Financial Officer
|
Chief Financial Officer | Total investments: 0 | Find email | |
|
Maxim Owen
Principal
|
Principal | Total investments: 0 | Find email | |
|
Brian Kadota
Med-Tech Analyst
|
Med-Tech Analyst | Total investments: 0 | Find email | |
Eric Manlunas
Investment Committee
|
Investment Committee | Total investments: 17 | Find email | |
Eric Marton
Venture Partner
|
Venture Partner | Total investments: 0 | Find email | |
| See all 13 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Materna Medical
|
Materna Medical is a novel OBGYN platform company defining a $6B market with core technologies addressing unmet needs in women's pelvic health. With headquarters in Mountain View, California, Materna pulls from the top minds in MedTech to truly transform the standard of care in OBGYN. With a diverse team of engineers, scientists, researchers,and commercial leaders, Materna Medical’s mission is to empower women to protect their pelvic health. | $5M / Series B / Jul 01, 2026 | |
Tombot
|
Tombot specializes in creating robotic animals and digital health solutions. The company targets a market of over 200 million individuals living with dementia or pre-dementia mild cognitive impairment. Research has demonstrated that robotic animals can effectively alleviate behavioral and psychological symptoms associated with dementia, includingloneliness, anxiety, depression, hallucinations, and violent anger, while also reducing the dependence on harmful psychotropic medications. Tombot’s mission is encapsulated in its tagline, "A dog for people who can’t have dogs. | $7M / Series A / Jun 25, 2026 | |
ChemT Biotechnology
|
The goal of ChemT Biotechnology is to increase patient access to the most cutting-edge biologics, beginning with the urgent issues in manufacturing and research and development. | $4M / Seed / Jun 22, 2026 | |
01Health
|
01Health is a health tech building an AI-powered clinical infrastructure platform for specialist healthcare delivery. | $15M / Series A / Jun 10, 2026 | |
Lium
|
Lium provides a platform that structures technical datasets and makes them accessible through natural language, enabling teams to analyze, understand. | $5.5M / Seed / Jun 10, 2026 | |
Hermes Health
|
Big IdeaHermes Health is a secure, neutral middleware platform that simplifies and standardizes access to identified patient health data. We connect Requestors (e.g., attorneys, CROs, analytics firms) with Partners (e.g., ROI vendors, EHR providers, RWD sources) who hold and manage this data.ProblemAccessing identified health data remainslargely manual and outdated—relying on phone calls, faxes, and mailed records. This process is fragmented, costly, and inefficient. Requestors face a maze of disconnected workflows, while Partners are bogged down by inconsistent standards and manual tasks.SolutionHermes Health offers a scalable API and the Unity Platform to power secure, patient-consented data workflows. We reduce integration complexity and contractual friction by enabling seamless connectivity between Requestors and our network of Partners.The Unity Platform integrates with Partners as they are—plugging into existing APIs or co-developing new ones to match their systems. Whether you're a requestor or a data custodian, Hermes Health accelerates access while preserving security and compliance. | $4.5M / Seed / Feb 01, 2025 | |
|
Lium
|
Lium provides a platform that structures technical datasets and makes them accessible through natural language, enabling teams to analyze, understand. | $2.5M / Seed / Nov 25, 2024 | |
Citizen Health
|
Over 350+ million people worldwide are affected by one of the 10,000+ rare diseases of which 95% do not have a single treatment available. Through our AI-powered platform, we liberate and structure data to radically improve rare and complex disease treatment, widen access to expert care, and revolutionize the development of new medicines at afraction of the speed previously proven possible. Patients can share their health data across our multi-sided platform with caregivers, providers and researchers to illuminate better treatment and support options, while bringing therapies to patients faster. We support thousands of patients, work with a rapidly growing network of patient advocacy organizations, and innovate with leading biopharma organizations to accelerate therapies, always ensuring patients remain at the center. | $14.5M / Seed / Nov 19, 2024 | |
Esperto Medical
|
Esperto Medical is an Irvine, CA-based medical device company developing next-generation wearable diagnostics that enable hospital-based and remote patient monitoring with unprecedented ease and accuracy. Its unique resonance sonomanometry technology uses acoustic stimulation to directly and noninvasively measure continuous blood pressure withoutcalibration. | Series A / Oct 24, 2024 | |
RubyWell
|
RubyWell is an intelligent and automated guide that helps family caregivers regain financial stability by continuously discovering and delivering new savings, benefits, and compensation opportunities. | $1.1M / Seed / Oct 17, 2024 | |
| See all 89 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Wavemaker 360 invest in?
Wavemaker 360 invests primarily in Health Care, Medical and Artificial Intelligence startups, most often at Seed and Series A stage. Most of the 89 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Wavemaker 360's check size?
Wavemaker 360 typically joins rounds of $750k–$6M at Seed, $1.9M–$20M at Series A and $5M–$30M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Wavemaker 360 participates in.
How do I contact Wavemaker 360?
Public channels for Wavemaker 360 include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Wavemaker 360?
The team at Wavemaker 360 includes Lisa Riedmiller (Chief Financial Officer), Maxim Owen (Principal) and Brian Kadota (Med-Tech Analyst), among 13 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
